The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease

INTRODUCTION: The increasing financial burden associated with diabetes treatment presents a challenge to healthcare systems worldwide. Recently, clinical guidelines have focussed on patients with type 2 diabetes (T2D) and established cardiovascular disease (CVD) and recommend a sodium-glucose co-tra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Ther
Hauptverfasser: Ehlers, Lars Holger, Lamotte, Mark, Monteiro, Sofia, Sandgaard, Susanne, Holmgaard, Pia, Frary, Evan C., Ejskjaer, Niels
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Healthcare 2021
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8099952/
https://ncbi.nlm.nih.gov/pubmed/33856655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-021-01040-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge